Population impact of different definitions of airway obstruction

被引:220
作者
Celli, BR
Halbert, RJ
Isonaka, S
Schau, B
机构
[1] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[2] Constella Hlth Strategies, Santa Monica, CA USA
[3] Univ Calif Los Angeles, Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90024 USA
[4] Boehringer Ingelheim GmbH & Co KG, Dept Market Access Pricing & Outcomes Res, Ingelheim, Germany
关键词
chronic obstructive pulmonary disease; prevalence; spirometry; USA;
D O I
10.1183/09031936.03.00075102
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
There is currently no consensus on the criteria for diagnosing chronic obstructive pulmonary disease. This study evaluated the impact of different definitions of airway obstruction on the estimated prevalence of obstruction in a population-based sample. Using the Third National Health and Nutrition Examination Survey, obstructive airway disease was defined using the following criteria: 1) self-reported diagnosis of chronic bronchitis or emphysema; 2) forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) <0.70 and FEV1 <80% predicted (Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage IIA); 3) FEV1/FVC below the lower limit of normal; 4) FEV1/FVC <88% pred in males and <89% pred in females; 5) FEV1/FVC <0.70 ("fixed ratio"). Spirometry in this dataset did not include reversibility testing, making it impossible to distinguish reversible from irreversible obstruction. Rates in adults varied from 77 per 1,000 (self-report) to 168 per 1,000 (fixed ratio). For persons aged >50 yrs, the fixed ratio criteria produced the highest rate estimates. For all subgroups tested, the GOLD Stage II criteria produced lower estimates than other spirometry-based definitions. Different definitions of obstruction may produce prevalence estimates that vary by >200%. International opinion leaders should agree upon a clear definition of chronic obstructive pulmonary disease that can serve as a population-based measurement criterion as well as a guide to clinicians.
引用
收藏
页码:268 / 273
页数:6
相关论文
共 31 条
[1]  
American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P77
[2]   LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[3]  
[Anonymous], 1987, Am Rev Respir Dis, V136, P1285
[4]  
Brogger JC, 2000, INT J TUBERC LUNG D, V4, P83
[5]   Vital capacities in acute and chronic airway obstruction: Dependence on flow and volume histories [J].
Brusasco, V ;
Pellegrino, R ;
Rodarte, JR .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (06) :1316-1320
[6]   COPD - Early detection and intervention [J].
Calverley, PMA .
CHEST, 2000, 117 (05) :365S-371S
[7]   Forced vital capacity, slow vital capacity, or inspiratory vital capacity: Which is the best measure of vital capacity? [J].
Chhabra, SK .
JOURNAL OF ASTHMA, 1998, 35 (04) :361-365
[8]  
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
[9]  
GILDEA TR, 2002, AM J RESP CRIT CARE, V165, pA200
[10]  
Glissmeyer EW, 1999, AM J RESP CRIT CARE, V159, pA834